The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Charlotte Ling

Charlotte Ling

Professor

Charlotte Ling

NIH working group report-using genomic information to guide weight management: From universal to precision treatment.

Author

  • Molly S Bray
  • Ruth J F Loos
  • Jeanne M McCaffery
  • Charlotte Ling
  • Paul Franks
  • George M Weinstock
  • Michael P Snyder
  • Jason L Vassy
  • Tanya Agurs-Collins

Summary, in English

Precision medicine utilizes genomic and other data to optimize and personalize treatment. Although more than 2,500 genetic tests are currently available, largely for extreme and/or rare phenotypes, the question remains whether this approach can be used for the treatment of common, complex conditions like obesity, inflammation, and insulin resistance, which underlie a host of metabolic diseases.

Department/s

  • Genomics, Diabetes and Endocrinology
  • Diabetes - Epigenetics
  • Genetic and Molecular Epidemiology
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health

Publishing year

2016

Language

English

Pages

14-22

Publication/Series

Obesity

Volume

24

Issue

1

Document type

Journal article review

Publisher

Nature Publishing Group

Topic

  • Endocrinology and Diabetes

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology
  • Diabetes - Epigenetics
  • Genetic and Molecular Epidemiology

ISBN/ISSN/Other

  • ISSN: 1930-739X